Details emerge in federal case against Stryker Biotech

October 29, 2009 by MassDevice staff

A federal indictment of the Hopkinton, Mass.-based company and some of its top managers sheds light on the charges against them and the company.

Details emerge in federal case against Stryker Biotech

A federal indictment brought by a Boston grand jury against Stryker Biotech sheds light on the charges against the company and the four managers charged with a two-year campaign to promote the off-label combination of two bone growth products and lying to the FDA.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp